Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

DSpace Repository

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Author: Hehlmann, R.; Lauseker, M.; Saussele, S.; Pfirrmann, M.; Krause, S.; Kolb, H. J.; Neubauer, A.; Hossfeld, D. K.; Nerl, C.; Gratwohl, A.; Baerlocher, G. M.; Heim, D.; Bruemmendorf, T. H.; Fabarius, A.; Haferlach, C.; Schlegelberger, B.; Mueller, M. C.; Jeromin, S.; Proetel, U.; Kohlbrenner, K.; Voskanyan, A.; Rinaldetti, S.; Seifarth, W.; Spiess, B.; Balleisen, L.; Goebeler, M. C.; Haenel, M.; Ho, A.; Dengler, J.; Falge, C.; Kanz, L.; Kremers, S.; Burchert, A.; Kneba, M.; Stegelmann, F.; Koehne, C. A.; Lindemann, H. W.; Waller, C. F.; Pfreundschuh, M.; Spiekermann, K.; Berdel, W. E.; Mueller, L.; Edinger, M.; Mayer, J.; Beelen, D. W.; Bentz, M.; Link, H.; Hertenstein, B.; Fuchs, R.; Wernli, M.; Schlegel, F.; Schlag, R.; de Wit, M.; Truemper, L.; Hebart, H.; Hahn, M.; Thomalla, J.; Scheid, C.; Schafhausen, P.; Verbeek, W.; Eckart, M. J.; Gassmann, W.; Pezzutto, A.; Schenk, M.; Brossart, P.; Geer, T.; Bildat, S.; Schaefer, E.; Hochhaus, A.; Hasford, J.
Tübinger Autor(en):
Kanz, Lothar
Published in: Leukemia (2017), Bd. 31, H. 11, S. 2398-2406
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2017.253
ISSN: 1476-5551
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)